August 2025
1. OKUDAN B, Atalay M, Hakkoymaz ZR, Seven B, et al
   Diagnostic value of presurgical 68Ga-PSMA-11 PET/CT in prostate cancer patients with different ISUP grade groups.
   Nuklearmedizin. 2025 Aug 22. doi: 10.1055/a-2665-8087.
   

   >> Share

   
   
2. JOZANOVIC V, Lukic D, Brataljenovic M, Huic D, et al
   Diagnostic challenge in parathyroid imaging: incidental schwannoma mimicking primary hyperparathyroidism on 18F-fluorocholine PET/CT.
   Nuklearmedizin. 2025 Aug 22. doi: 10.1055/a-2655-5291.
   

   >> Share

   
   
3. TATOGLU MT, Alan Selcuk N, Erincik K
   Benign bone lesions mimicking metastasis on 68Ga-FAPI PET/CT.
   Nuklearmedizin. 2025;64:277-280.
   

   >> Share

   
   
4. GAMMEL MCM, Hansen K, Weber W, Rauscher I, et al
   From Metastases to Splenosis: Resolving SSR PET Pitfalls with Tc-99m-Labeled Denatured Red Blood Cell Scintigraphy.
   Nuklearmedizin. 2025;64:272-273.
   

   >> Share

   
   June 2025
5. LIU S, Pan Q, Xu H, Luo Y, et al
   Activation of fibroblast in intestinal Behcet's disease shown by 68Ga-FAPI-04 PET/CT.
   Nuklearmedizin. 2025;64:231-233.
   

   >> Share

   
   
6. YANG H, Zhang Y, Guan Z, Li C, et al
   The diagnostic performance of an [18F]FDG PET/CT algorithm for preoperative evaluation of extrahepatic cholangiocarcinoma: a retrospective study.
   Nuklearmedizin. 2025;64:205-214.
   

   >> Share

   
   
7. DROPMANN JA, Kleespies A, Fuerst H, Kremer M, et al
   Importance of oxyphil cells for 99mTc-sestamibi uptake in primary hyperparathyroidism: a retrospective observational study.
   Nuklearmedizin. 2025;64:215-224.
   

   >> Share

   
   May 2025
8. WENDLER T, Rogasch JMM, Bastian MB, Burchert W, et al
   Correction: Digitalization of Nuclear Medicine in Germany - Status Quo 2024.
   Nuklearmedizin. 2025 May 20. doi: 10.1055/a-2604-5823.
   

   >> Share

   
   
9. BAEHR M, Dietrich I, Liepe K
   [99mTc]Tc-PSMA SPECT/CT is a promising tool in the staging of renal cell carcinoma.
   Nuklearmedizin. 2025 May 12. doi: 10.1055/a-2578-7222.
   

   >> Share

   
   April 2025
10. BUCHERT R, Drzezga A, Schreckenberger M, Langen KJ, et al
    The Status of Neuroimaging with SPECT and PET in Germany: Results from the 1st Survey on Nuclear Neuroimaging in Germany in 2023.
    Nuklearmedizin. 2025 Apr 15. doi: 10.1055/a-2566-1487.
    

    >> Share

    
    
11. LUNA R, Laheru DA, Shin EJ, Lossos C, et al
    Pancreatic Neuroendocrine Tumor incidentally found on 68Ga-PSMA PET/CT.
    Nuklearmedizin. 2025;64:177-179.
    

    >> Share

    
    
12. WENDLER T, Rogasch JMM, Bastian MB, Burchert W, et al
    Digitalization of Nuclear Medicine in Germany - Status Quo 2024.
    Nuklearmedizin. 2025;64:156-162.
    

    >> Share

    
    
13. ORBOM A, Evans-Axelsson S, Jansson B, Vilhelmsson Timmermand O, et al
    Intratumoral distribution and pharmacokinetics of the radiolabeled ICAM-1 targeting monoclonal antibody R6.5 in a prostate cancer mouse model.
    Nuklearmedizin. 2025;64:163-169.
    

    >> Share

    
    
14. EBRAHIMIFARD A, Rajabi H, Geramifar P, Luster M, et al
    The impact of the xSPECT reconstruction algorithms on the recovery coefficients value for small tumors: a phantom study with 177Lu.
    Nuklearmedizin. 2025;64:132-140.
    

    >> Share

    
    
15. VOGT JK, Vogt WK, Heinzel A, Mottaghy FM, et al
    Comparison of 2D and 3D lung lobe quantification with Ventilation/Perfusion Ratio.
    Nuklearmedizin. 2025;64:142-149.
    

    >> Share

    
    March 2025
16. BAUDE JK, Mottaghy FM, Derlin T, Fischer A, et al
    PSMA - Targeted Clinical Molecular Imaging of Atherosclerosis: Correlation with Cardiovascular Risk Factors.
    Nuklearmedizin. 2025;64:13-21.
    

    >> Share

    
    January 2025
17. VURAL TOPUZ O, Bagbudar S, Aksu A, Soylemez Akkurt T, et al
    Radiomic signatures derived from baseline 18F FDG PET/CT imaging can predict tumor-infiltrating lymphocyte values in patients with primary breast cancer.
    Nuklearmedizin. 2025 Jan 28. doi: 10.1055/a-2512-8212.
    

    >> Share

    
    December 2024
18. CEGLA P, Currie G, Wroblewska JP, Kazmierska J, et al
    [18F]FDG PET/CT Imaging and Hematological Parameters Can Help Predict HPV Status in Head and Neck Cancer.
    Nuklearmedizin. 2024 Dec 4. doi: 10.1055/a-2365-7808.
    

    >> Share

    
    
19. GRUNERT M, Schenke SA, Konrad A, Schutze C, et al
    Thyroid scintigraphy: establishing a clinically useful normal range for 99mTc pertechnetate uptake.
    Nuklearmedizin. 2024;63:337-346.
    

    >> Share

    
    November 2024
20. RUGGIERO C, Maracaja D, Rowe SP
    Langerhans Cell Histiocytosis-Associated Vertebra Plana on FDG PET.
    Nuklearmedizin. 2024 Nov 27. doi: 10.1055/a-2438-7469.
    

    >> Share

    
    
21. ZHAO G, Huang Z
    A Case of Thoracic SMARCA4-Deficient Undifferentiated Tumor on 18F-FDG PET/CT.
    Nuklearmedizin. 2024 Nov 20. doi: 10.1055/a-2383-2527.
    

    >> Share

    
    
22. SCHULZ L, Funk GC, Kirchbacher K, Egger E, et al
    Comparison of whole-body 18F-FDG-PET/CT with 18F-FDG-PET/CT limited to skull base to upper abdomen for primary staging of lung cancer - a retrospective explorative analysis.
    Nuklearmedizin. 2024 Nov 11. doi: 10.1055/a-2438-7278.
    

    >> Share

    
    October 2024
23. VOLTIN CA, Spreckelmeyer S, Essler M, Holzgreve A, et al
    Toward the future of nuclear medicine: How young professionals are getting involved and what plans they have.
    Nuklearmedizin. 2024;63:284-286.
    

    >> Share

    
    
24. VOGEL J, Haghghi S, Herkula C, Petersen M, et al
    Interobserver Agreement of visual and semi-quantitative methods in 99mTc-Methoxy-Isobuty-Isonitrile (MIBI) imaging for risk stratification of hypofunctional thyroid nodules.
    Nuklearmedizin. 2024;63:294-299.
    

    >> Share

    
    
25. ZEIDLER R, Tiepolt S, Hesse S, Sabri O, et al
    Superimposing kidneys in [99mTc]MAG-3 and [99mTc]DMSA-scintigraphy in a tricky case of an extensive, displacing growing retroperitoneal liposarcoma.
    Nuklearmedizin. 2024;63:306-307.
    

    >> Share

    
    September 2024
26. JAFARI E, Manafi-Farid R, Ahmadzadehfar H, Salek F, et al
    Prognostic Significance of Baseline Clinical and [68Ga]Ga-PSMA PET Derived Parameters on Biochemical Response, Overall Survival, and PSA Progression-Free Survival in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Undergoing [177Lu]Lu
    Nuklearmedizin. 2024 Sep 3. doi: 10.1055/a-2365-8113.
    

    >> Share

    
    August 2024
27. RAHBAR NIKOUKAR L, Seifert R, Ventura D, Schindler P, et al
    Prognostic value of pretherapeutic 68Ga-PSMA-11-PET based imaging parameters in mCRPC patients treated with PSMA radioligands.
    Nuklearmedizin. 2024 Aug 29. doi: 10.1055/a-2383-2468.
    

    >> Share

    
    
28. VOGT JK, Vogt WK, Heinzel A, Mottaghy FM, et al
    Computational Decision Support for PE Diagnosis based on Ventilation Perfusion Ratio.
    Nuklearmedizin. 2024;63:259-266.
    

    >> Share

    
    July 2024
29. LANDAU F, Hermann S, Schelhaas S, Schafers M, et al
    18F-labelled gentiobiose as potential PET-radiotracer for specific bacterial imaging: precursor synthesis, radiolabelling and in vitro evaluation.
    Nuklearmedizin. 2024 Jul 31. doi: 10.1055/a-2365-8054.
    

    >> Share

    
    
30. BREDENSTEINER L, Ventura D, Rassek P, Schafers M, et al
    Determination of the optimal imaging protocol for [18F]PSMA-PET-CT for the detection of bone metastases in prostate cancer patients.
    Nuklearmedizin. 2024 Jul 12. doi: 10.1055/a-2344-6825.
    

    >> Share

    
    May 2024
31. SCHMIDT M, Hohberg M, Felcht M, Kuhn T, et al
    [Nuclear medicine procedure guideline for sentinel lymph node localization].
    Nuklearmedizin. 2024 May 24. doi: 10.1055/a-2319-8306.
    

    >> Share

    
    
32. HEIDEMANNS S, Trautmann S, Weidt D, Hellwig D, et al
    Update of the competence-based catalog of learning objectives in nuclear medicine for the study of human medicine in Germany.
    Nuklearmedizin. 2024 May 22. doi: 10.1055/a-2319-7549.
    

    >> Share

    
    April 2024
33. WIELENBERG CF, Fostitsch JC, Volz C, Marks R, et al
    FDG-PET/CT is a powerful tool to predict and evaluate response to chimeric antigen receptor (CAR) T-cell therapy in Non-Hodgkin-Lymphoma (NHL).
    Nuklearmedizin. 2024 Apr 9. doi: 10.1055/a-2283-8417.
    

    >> Share

    
    
34. BOCK F, Frerker B, Schubert L, Rennau H, et al
    Impact of 68Ga-PSMA PET/CT on radiation treatment planning of prostate cancer patients.
    Nuklearmedizin. 2024 Apr 5. doi: 10.1055/a-2284-0593.
    

    >> Share

    
    
35. SAEED S, Dimopoulos I, Begum N, Kroger JR, et al
    [Not Available].
    Nuklearmedizin. 2024;63:78-80.
    

    >> Share

    
    
36. WERNER R, Haug A, Buske C, Heidegger S, et al
    CXCR4-targeted Theranostics in Hematooncology: Opportunities and Challenges.
    Nuklearmedizin. 2024;63:57-61.
    

    >> Share

    
    March 2024
37. GACULA SIG, Kunte SC, Unterrainer LM, Rubenthaler J, et al
    Correction: Divergent growth on [18F]FDG PET/CT in a case of co-existing pulmonary metastatic leiomyosarcoma and papillary thyroid carcinoma.
    Nuklearmedizin. 2024 Mar 25. doi: 10.1055/a-2286-9571.
    

    >> Share

    
    
38. USLU H, Sahin D, Tatoglu MT, Ibisoglu E, et al
    Growing Teratoma Syndrome Revealed By F-18 FDG PET/CT.
    Nuklearmedizin. 2024 Mar 14. doi: 10.1055/a-2273-2350.
    

    >> Share

    
    
39. GACULA SIG, Kunte SC, Unterrainer LM, Rubenthaler J, et al
    Divergent growth on [18F]FDG PET/CT in a case of co-existing pulmonary metastatic leiomyosarcoma and papillary thyroid carcinoma.
    Nuklearmedizin. 2024 Mar 11. doi: 10.1055/a-2273-2447.
    

    >> Share

    
    
40. LIU Y, Tang W, Huang Z
    Correction: 99mTc-MDP Bone Scan and 18F-FDG PET/CT Imaging of Primary Hepatic Osteosarcoma.
    Nuklearmedizin. 2024 Mar 4. doi: 10.1055/a-2275-1035.
    

    >> Share

    
    February 2024
41. CHEN M, Liu Y
    Correction: 18F-FDG PET/CT images of adult pulmonary blastoma: a case report.
    Nuklearmedizin. 2024 Feb 20. doi: 10.1055/a-2265-4049.
    

    >> Share

    
    
42. AYDAR S, Knobl H, Burchert W, Lindner O, et al
    Diagnostic accuracy of artificial intelligence-enabled vectorcardiography versus myocardial perfusion SPECT in patients with suspected or known coronary heart disease.
    Nuklearmedizin. 2024 Feb 20. doi: 10.1055/a-2263-2322.
    

    >> Share

    
    
43. CHEN M, Liu Y
    18F-FDG PET/CT images of adult pulmonary blastoma: a case report.
    Nuklearmedizin. 2024 Feb 7. doi: 10.1055/a-2237-8775.
    

    >> Share

    
    
44. UMUTLU L, Nensa F, Demircioglu A, Antoch G, et al
    Radiomics Analysis of Multiparametric PET/MRI for N- and M-Staging in Patients with Primary Cervical Cancer.
    Nuklearmedizin. 2024;63:34-42.
    

    >> Share

    
    
45. FISCHER M, Schneider-Eicke J
    Nonosseous bone seeking tracer focal uptake in the conventional scintigraphy.
    Nuklearmedizin. 2024;63:45-47.
    

    >> Share

    
    
46. DIETLEIN M, Grunwald F, Schmidt M, Kreissl MC, et al
    [Guideline for Radioiodine Therapy for Benign Thyroid Diseases (6/2022 - AWMF No. 031-003)].
    Nuklearmedizin. 2024;63:8-20.
    

    >> Share

    
    January 2024
47. FREUDENBERG R, Kastner D, Kotzerke J, Brogsitter C, et al
    [Evaluation of risk analysis in treatment with unsealed radioactive substances in nuclear medicine].
    Nuklearmedizin. 2024 Jan 23. doi: 10.1055/a-2237-8639.
    

    >> Share

    
    
48. MAMAN A
    Incidental Papillary Thyroid Carcinoma Detected by Ga-68 DOTATATE PET/CT: A Rare Case Study and Clinical Considerations.
    Nuklearmedizin. 2024 Jan 23. doi: 10.1055/a-2238-4186.
    

    >> Share

    
    
49. NOURBAKHSH S, Salehi Y, Farzanehfar S, Ghaletaki R, et al
    FAPI PET/CT provides higher uptake and better target to back ground in recurrent and metastatic tumors of patients with Iodine refractory papillary thyroid cancer compared with FDG PET CT.
    Nuklearmedizin. 2024 Jan 8. doi: 10.1055/a-2185-7746.
    

    >> Share

    
    
50. ARSLANTAS E, Aycicek A, Esen Akkas B, Tahtakesen Gucer TN, et al
    The Role of FDG- PET/CT in Detecting Bone Marrow Involvement in Childhood Solid Tumors.
    Nuklearmedizin. 2024 Jan 8. doi: 10.1055/a-2224-9441.
    

    >> Share

    
    
51. VURAL TOPUZ O, Bagbudar S
    Cervical Cancer Metastasis to the Stomach Masquerading as Primary Gastric Cancer: A Case Report of a Rare Metastasis Detected via 18F-FDG PET/CT.
    Nuklearmedizin. 2024 Jan 8. doi: 10.1055/a-2224-9673.
    

    >> Share

    
    
52. SANTO G, Di Santo G, Zelger B, Virgolini I, et al
    Incidental Finding of a Pancreatic Adenocarcinoma on [68Ga]Ga-PSMA-11 PET/CT in a mCRPC patient under [177Lu]Lu-PSMA-617 Radioligand Therapy.
    Nuklearmedizin. 2024 Jan 8. doi: 10.1055/a-2221-3220.
    

    >> Share

    
    December 2023
53. SERFLING SE, Buck A, Rowe SP, Higuchi T, et al
    Red Bull PET/CT.
    Nuklearmedizin. 2023 Dec 22. doi: 10.1055/a-2195-0138.
    

    >> Share

    
    
54. ROGASCH JMM, Shi K, Kersting D, Seifert R, et al
    Methodological evaluation of original articles on radiomics and machine learning for outcome prediction based on positron emission tomography (PET).
    Nuklearmedizin. 2023;62:361-369.
    

    >> Share

    
    
55. WENDLER T, Kreissl MC, Schemmer B, Rogasch JMM, et al
    Artificial Intelligence-powered automatic volume calculation in medical images - available tools, performance and challenges for nuclear medicine.
    Nuklearmedizin. 2023;62:343-353.
    

    >> Share

    
    
56. HELLWIG D, Hellwig NC, Boehner S, Fuchs T, et al
    Artificial Intelligence and Deep Learning for Advancing PET Image Reconstruction: State-of-the-Art and Future Directions.
    Nuklearmedizin. 2023;62:334-342.
    

    >> Share

    
    
57. MIEDERER I, Rogasch JMM, Wendler T
    AI in Nuclear Medicine - a review of the current situation.
    Nuklearmedizin. 2023;62:332-333.
    

    >> Share

    
    November 2023
58. LOHMANN P, Bundschuh RA, Miederer I, Mottaghy FM, et al
    Clinical Applications of Radiomics in Nuclear Medicine.
    Nuklearmedizin. 2023 Nov 7. doi: 10.1055/a-2191-3271.
    

    >> Share

    
    October 2023
59. FUCHS T, Kaiser L, Muller D, Papp L, et al
    Enhancing Interoperability and Harmonisation of Nuclear Medicine Image Data and Associated Clinical Data.
    Nuklearmedizin. 2023 Oct 31. doi: 10.1055/a-2187-5701.
    

    >> Share

    
    
60. RASSEK P, Bobe S, Kies P, Roll W, et al
    The value of core needle biopsy in the diagnostic workup of a [18F]FDG-PET positive thyroid metastasis from colorectal cancer.
    Nuklearmedizin. 2023 Oct 23. doi: 10.1055/a-2178-6908.
    

    >> Share

    
    
61. BROSCH-LENZ JF, Delker A, Schmidt F, Tran-Gia J, et al
    On the Use of Artificial Intelligence for Dosimetry of Radiopharmaceutical Therapies.
    Nuklearmedizin. 2023 Oct 12. doi: 10.1055/a-2179-6872.
    

    >> Share

    
    
62. MOON H, Ku EJ, Kim C
    Ectopic Thyroid Tissue in the Uterus Identified by Iodine-131 SPECT/CT.
    Nuklearmedizin. 2023;62:294-295.
    

    >> Share

    
    
63. KUSTNER T, Hepp T, Seith F
    Multiparametric Oncologic Hybrid Imaging: Machine Learning Challenges and Opportunities.
    Nuklearmedizin. 2023;62:306-313.
    

    >> Share

    
    September 2023
64. DEININGER K, Raacke JN, Yousefzadeh-Nowshahr E, Kropf-Sanchen C, et al
    Combined morphologic-metabolic biomarkers from [18F]FDG-PET/CT stratify prognostic groups in low-risk NSCLC.
    Nuklearmedizin. 2023 Sep 11. doi: 10.1055/a-2150-4130.
    

    >> Share

    
    
65. MIEDERER I, Rogasch JMM, Fischer R, Fuchs T, et al
    The Medical Informatics Initiative and the Network University Medicine - Perspectives for Nuclear Medicine.
    Nuklearmedizin. 2023 Sep 8. doi: 10.1055/a-2067-7642.
    

    >> Share

    
    August 2023
66. FROHLICH M, Schmalzing M, Buck A, Bley TA, et al
    PET-Derived Increased Inflammation in Large Vessels is linked to Relapse-Free Survival in Patients with Giant Cell Arteritis.
    Nuklearmedizin. 2023;62:229-234.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share